Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for ALR
37.58
+0.38 (1.02%)
After Hours: 37.58 0.00 (0.00%)
Dec 9, 4:02PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 37.02 - 37.99
52 week 31.47 - 54.13
Open 37.50
Vol / Avg. 457,177.00/879,741.00
Mkt cap 3.33B
P/E     -
Div/yield     -
EPS -0.88
Shares 87.00M
Beta 0.63
Inst. own 95%
Nov 4, 2016
Q3 2016 Alere Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -0.71% -1.15%
Operating margin 0.59% 5.60%
EBITD margin - 13.65%
Return on average assets -0.28% -0.45%
Return on average equity 4.65% -2.50%
Employees 9,200 -
CDP Score - 73 E

Address

51 Sawyer Rd Ste 200
WALTHAM, MA 02453-3448
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Officers and directors

Gregg J. Powers Independent Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Namal Nawana President, Chief Executive Officer, Director
Age: 45
Bio & Compensation  - Reuters
James F. Hinrichs Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Daniella Cramp Global President - Cardiometabolic Business Unit
Age: 42
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 46
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease Business Unit
Age: 53
Bio & Compensation  - Reuters
Ellen Chiniara J.D. Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Secretary
Age: 57
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 69
Bio & Compensation  - Reuters
Mark Gladwell Senior Vice President - Global Operations
Age: 41
Bio & Compensation  - Reuters
Melissa Guerdan Senior Vice President - Global Quality and Regulatory Assurance
Age: 42
Bio & Compensation  - Reuters